pharmakoökonomie

Pharmakoökonomie, also known as pharmacoeconomics, is a subfield of health economics that studies the costs and effects of pharmaceutical products and services. Its primary goal is to identify the most cost-effective pharmaceutical interventions to improve patient outcomes and optimize resource allocation within healthcare systems. This involves analyzing not only the direct costs of medications but also indirect costs such as hospitalization, physician visits, and patient productivity losses.

Key methodologies employed in pharmakoökonomie include cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis. Cost-effectiveness analysis compares the costs of different interventions relative to a common unit of health outcome, like years of life saved. Cost-utility analysis extends this by incorporating quality of life into the outcome measure, often using measures like Quality-Adjusted Life Years (QALYs). Cost-benefit analysis, less commonly used in pharmaceuticals due to valuation challenges, attempts to express both costs and benefits in monetary terms.

The insights generated by pharmakoökonomie are crucial for decision-makers in healthcare. These include pharmaceutical manufacturers, regulatory agencies, health insurers, and healthcare providers. By providing evidence-based assessments of value, pharmakoökonomie helps inform pricing decisions, reimbursement policies, formulary management, and the adoption of new drugs and therapies, ultimately aiming to ensure that valuable pharmaceutical innovations are accessible and affordable.